Determination of liver fibrosis stages in Egyptian chronic hepatitis B patients by a noninvasive tool

Serag, Waleed Mohamed; Mohamed, Magdy; Elsayed, Basem Eysa; Abd-Elhamed, Sara Mahmoud;

Abstract


Hepatitis B virus (HBV) infection is the leading cause of liver fibrosis (LF). The prognosis and management of patients with chronic hepatitis B virus depend on the amount and progression of liver fibrosis. Angiopoietin-like protein 2 (Angptl2) is not only a chronic inflammatory mediator, but also a tissue-remodeling factor. The aim of this study is to explore the predictive value of Angptl2 in different fibrosis stages in patients chronically infected with HBV.


Other data

Title Determination of liver fibrosis stages in Egyptian chronic hepatitis B patients by a noninvasive tool
Authors Serag, Waleed Mohamed; Mohamed, Magdy ; Elsayed, Basem Eysa; Abd-Elhamed, Sara Mahmoud
Keywords HBsAg;stage of fibrosis;angiopoietin-like protein 2;APRI;FIB-4
Issue Date 8-Aug-2019
Journal Turkish journal of medical sciences 
Volume 49
Issue 4
ISSN 13000144
DOI 10.3906/sag-1812-165
PubMed ID 31385666
Scopus ID 2-s2.0-85071353115

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.